| PERIOD ENDING | 28-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 194,078 | 181,913 | 158,950 | 237,267 | | Cost of Revenue | 109,404 | 104,222 | 92,420 | 141,219 | | | Gross Profit | 84,674 | 77,691 | 66,530 | 96,048 | | | Operating Expenses | | Research Development | 4,874 | 4,753 | 5,184 | 6,340 | | Selling General and Administrative | 66,210 | 61,597 | 61,917 | 74,208 | | Non Recurring | (1,147) | 572 | 1,787 | 70,419 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 13,437 | 10,769 | (2,358) | (54,919) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,404) | 737 | 1,003 | (6,121) | | Earnings Before Interest And Taxes | 13,333 | 11,506 | (1,355) | (61,040) | | Interest Expense | 1,878 | 1,903 | 1,282 | 1,760 | | Income Before Tax | 11,455 | 9,603 | (2,637) | (62,800) | | Income Tax Expense | 8,884 | 2,718 | (412) | (1,059) | | Minority Interest | 332 |
-
|
-
| 6 | | | | Net Income From Continuing Ops | 2,903 | 6,885 | (2,225) | (61,735) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,903 | 6,885 | (2,225) | (61,735) | | Preferred Stock And Other Adjustments | (264) | 45 | 219 |
-
| | | Net Income Applicable To Common Shares | $2,639 | $6,930 | ($2,006) | ($61,735) |
|
0.31% Nasdaq 
0.05%
Income Statement
